Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
QuintilesIMS
Chinese Patent Office
McKesson
Julphar
Merck
AstraZeneca
Covington
Harvard Business School

Generated: September 19, 2018

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 040701

« Back to Dashboard

NDA 040701 describes ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE, which is a drug marketed by Mikart, Wraser Pharms Llc, Boca Pharma Llc, and West-ward Pharm Corp, and is included in five NDAs. It is available from one supplier. Additional details are available on the ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE profile page.

The generic ingredient in ACETAMINOPHEN, CAFFEINE, AND DIHYDROCODEINE BITARTRATE is acetaminophen; caffeine; dihydrocodeine bitartrate. There are sixty-six drug master file entries for this compound. Six suppliers are listed for this compound. Additional details are available on the acetaminophen; caffeine; dihydrocodeine bitartrate profile page.

Profile for product number 001

Active Rx/OTC/Discontinued:DISCNDosage:TABLET;ORALStrength712.8MG;60MG;32MG
Approval Date:Apr 3, 2007TE:RLD:No

Complete Access Available with Subscription

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Teva
Healthtrust
Boehringer Ingelheim
Cipla
Covington
Dow
Baxter
Cantor Fitzgerald

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.